BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Avera Pharmaceuticals, Inc. Names Joao Siffert, M.D. As Vice President, Clinical Research And Development


10/19/2005 5:08:52 PM

SAN DIEGO, June 9 /PRNewswire/ -- Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses, today announced the appointment of Joao Siffert, M.D., as Vice President, Clinical Research and Development. Dr. Siffert joins Avera from Pfizer, where he was employed as a medical director since 2002, where he initially worked in the area of migraine and ultimately headed the worldwide medical team for Lyrica (pregabalin) and Neurontin in the areas of epilepsy and pain. Dr. Siffert's contributions were instrumental for the Phase IIIb and IV clinical program as well as the global product launch.

"Joao Siffert comes to Avera with experience both as a clinical investigator in academic medicine, and as a pharmaceutical physician who has been a medical leader of major CNS (central nervous system) therapeutics at Pfizer," said Jeffrey McKelvy, president and chief executive officer of Avera Pharmaceuticals, Inc. "This breadth of background in clinical research is a major asset to Avera's drug development capability."

Prior to joining Pfizer, Dr. Siffert had a distinguished academic career that included positions at Beth Israel Medical Center, where he served as director of their Adult Neuro-oncology program, and Albert Einstein College of Medicine, where he was a faculty member in the department of neurology. He received his M.D. degree from the University of Sao Paulo School of Medicine, completed residencies in pediatrics at New York University School of Medicine and in neurology at Harvard Medical School, and held a clinical fellowship in Neuro-oncology at New York University School of Medicine. He also holds an MBA degree from Columbia Business School in New York.

Avera Pharmaceuticals, Inc.

Avera Pharmaceuticals, Inc. (San Diego, CA) is a private, emerging pharmaceutical company focused on the development and commercialization of novel compounds in the neuroscience therapeutics arena. The Company's mission is to identify opportunities for therapeutic advances in the treatment of neurologic and psychiatric disorders, and to in-license and develop compounds that can meet these needs. Additional information on the Company can be found at www.averapharm.com.

Avera Pharmaceuticals, Inc.

CONTACT: Jeffrey F. McKelvy, President and CEO of Avera Pharmaceuticals,Inc., +1-858-847-0650; or Joan Kureczka of Kureczka



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES